The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1148
ISSUE1148
January 20, 2003
Oxaliplatin (Eloxatin) for Advanced Colon Cancer
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Oxaliplatin (Eloxatin) for Advanced Colon Cancer
January 20, 2003 (Issue: 1148)
Oxaliplatin (Eloxatin -Sanofi-Synthelabo) has been approved by the FDA for use in combination with fluorouracil (5-FU; Adrucil, and others) and leucovorin (LV; Wellcovorin) for patients with metastatic colorectal cancer whose disease has recurred or...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.